Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

TIQUE

Financiado

InnovaTIve care services enhanced with technology to deliver QUick rEsponses f...

InnovaTIve care services enhanced with technology to deliver QUick rEsponses for individuals with advanced heart failure and complex care needs through integrated care Heart failure (HF) is the leading cause of hospitalisation in people over the age of 65 and carries a high cost to healthcare systems. It also exerts a significant economic toll on patients, their families and society in general;... ver más

28/02/2026

FGSHSCSP

6M€

Presupuesto del proyecto: 6M€

Líder del proyecto

FUNDACIO DE GESTIO SANITARIA DE L'HOSPITAL DE... No se ha especificado una descripción o un objeto social para esta compañía.

Ver 8 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2021-02-02

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

SC1-BHC-20A-2020: Pre-commercial procurement (PCP) for integrated care solutions

I+D

Cerrada hace 4 años

0% 90% 100%

8 Participantes

FGSHSCSP

4.55M€ | Lider

JERA Consulting

113.87K€ | Participante

Region Västerbotten

273.17K€ | Participante

AGENCIA DE QUALITAT I AVALUA...

74.67K€ | Participante

Últimas noticias

29-11-2024: IDAE En las últimas 48 horas el Organismo IDAE ha otorgado 4 concesiones

29-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 2 concesiones

29-11-2024: CMVAMADRID En las últimas 48 horas el Organismo CMVAMADRID ha otorgado 37 concesiones

Duración del proyecto: 60 meses Fecha Inicio: 2021-02-02
Fecha Fin: 2026-02-28

Presupuesto del proyecto 6M€

Descripción del proyecto Heart failure (HF) is the leading cause of hospitalisation in people over the age of 65 and carries a high cost to healthcare systems. It also exerts a significant economic toll on patients, their families and society in general; more the 15 million people are living with HF in Europe. Despite the considerable burden to human life and healthcare costs there has been scarce innovation in treatments in the past several decades: HF occurs mainly in the older population that may mistake symptoms as being the natural result of ageing and therefore not recognized until the condition has reached a severe stage. Poor management of HF increases the risk and frequency of acute episodes resulting in hospitalizations, poor quality of life and high burden on healthcare systems. The recent COVID-19 pandemic has evidenced that fearing to be infected, cardiovascular patients delay care. A state-of-the-art search indicated that that integrated care is crucial for improving the health care services, wellbeing and engagement through shared decision-making, education and support to self-management. Existing solutions are local and there is no common effective solution available in the market. Public procurers cannot go to open tender to deploy effective solutions for advanced heart failure. The TIQUE Consortium recognised Pre-Commercial Procurement (PCP) as the only way to stimulate the market to find a solution to the common problem. TIQUE will bring to the market new integrated care solutions implementing a predictive, preventive, personalized and participatory model of health care services for patients with heart failure. TIQUE will stimulate European industry to become a global leader in this innovative field. Use of PCP is of particular interest to the consortium members some of them are familiar with PCP and PPI and in using them strategically while others are new adopters. The consortium will proactively share PCP knowledge with the PiPPI and EURIPHI communities of practice.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores